As of August 28, 2026, Anbio Biotechnology (NNNN) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. Anbio Biotechnology has a market capitalization of $1.51B, 43.67M shares outstanding, 8 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NNNN.
Market Data
Market Cap$1.51B
Shares Outstanding43.67M
Float39.69M
Cash$11.90M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 102.6% shares (2026Q1 vs prior)
8 institutional holders · 60.3K shares
#1
GEODE CAPITAL MANAGEMENT, LLC
25.8K shares
#2
MORGAN STANLEY
16.0K shares
#3
BNP PARIBAS FINANCIAL MARKETS
10.4K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest47.5K
Days to Cover1.2
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track NNNN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NNNN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for NNNN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.